🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT04194671
Treatments Being Tested
This Phase IIB, multicenter, double-blind, randomized, and uncontrolled cli...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT06905834
The purpose of this study is to assess the safety and tolerability of intra...
Status
Not Yet Recruiting
Location
The University of Chicago
Start Date
2026-09
Trial ID
NCT07739043
Treatments Being Tested
The purpose of this study is to test a novel dendritic cell (DC) vaccine in...
Status
Completed
Location
Mary Crowley Medical Research Center: Baylor University Medical Center
Start Date
2005-07
Trial ID
NCT00125749
Treatments Being Tested
This Phase 2, multi-center, open-label extension trial will provide CAP-100...
Status
Completed
Location
University of Florida
Start Date
2018-06-21
Trial ID
NCT06304064
Treatments Being Tested
RATIONALE: Studying samples of semen from cancer survivors in the laborator...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2010-02
Trial ID
NCT01077440
Treatments Being Tested
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
The investigators propose a nonrandomized, Phase I study to assess the safe...
Status
Withdrawn
Location
Hammersmith Hospital
Start Date
2011-04
Trial ID
NCT01336478
A3D is a phase I/II clinical trial. The primary objective is to evaluate th...
Status
Recruiting
Location
University Hospital of Toulouse
Start Date
2026-05-07
Trial ID
NCT07367815
Protocol Summary * Title: A Phase I study of ExoFlo, an ex vivo culture-ex...
Status
Terminated
Location
Direct Biologics Investigational Site
Start Date
2022-12-19
Trial ID
NCT05176366
Treatments Being Tested